Literature DB >> 23895537

Left atrial work in patients with stable chronic heart failure: factors associated and prognostic role.

Carmine Mazzone1, Giovanni Cioffi, Giorgio Faganello, Antonella Cherubini, Luigi Tarantini, Andrea Di Lenarda, Tiziano Edoardo Russo, Alessandro Selmi, Carlo Stefenelli, Francesco Furlanello.   

Abstract

BACKGROUND: Limited information is available on left atrial (LA) work in chronic heart failure (CHF) patients. We evaluated correlates and prognostic role of LA work in 243 CHF patients using as reference for normal LA work values 230 healthy controls.
METHODS: Left atrial work was assessed by computation of LA kinetic energy (LAKE) from the formula: 0.5 × m × A(2) where m is LA stroke volume × blood density, and A is transmitral Doppler peak atrial velocity. The prespecified primary endpoint of the study was major cardiovascular (CV) events, a composite endpoint defined as CV death + hospitalization for heart failure (HF).
RESULTS: Left atrial kinetic energy was 3.9 ± 2.7 in CHF patients and 2.6 ± 1.4 Kdynes/m(2) in controls (P < 0.001). Abnormally high LAKE (>5.4 Kdynes/m(2) = mean + 2 SD of the controls) was found in 19% of CHF patients and 4% of controls (P < 0.001). LAKE was independently associated with an increased shortening of left ventricular (LV) longitudinal fibers and renal dysfunction. CV death or hospitalization for decompensated HF occurred in 66% and 20% of patients with abnormally high and normal LAKE, respectively (P < 0.001). Abnormally high LAKE, not LA size, was an independent predictor of events hazard ratio (HR) 3.92 [95% CI 1.96-7.84] together with renal dysfunction and lower LV ejection fraction.
CONCLUSION: In CHF patients, LAKE is significantly higher than in healthy controls, the prevalence of abnormally high LAKE is near fivefold higher in the former than in the latter. LAKE depends on systolic LV and renal function and is a strong predictor of CV death and hospitalization for HF. LA work has an incremental prognostic value over LA size.
© 2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  heart failure; kinetic energy; left atrial function; renal dysfunction

Mesh:

Year:  2013        PMID: 23895537     DOI: 10.1111/echo.12325

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction.

Authors:  Maria Prastaro; Carmen D'Amore; Stefania Paolillo; Mariangela Losi; Caterina Marciano; Cinzia Perrino; Donatella Ruggiero; Paola Gargiulo; Gianluigi Savarese; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

2.  Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography.

Authors:  Antonella Cherubini; Giovanni Cioffi; Carmine Mazzone; Giorgio Faganello; Giulia Barbati; Luigi Tarantini; Giulia Russo; Carlo Stefenelli; Franco Humar; Eliana Grande; Maurizio Fisicaro; Claudio Pandullo; Andrea Di Lenarda
Journal:  Cardiovasc Ultrasound       Date:  2016-06-01       Impact factor: 2.062

3.  Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.

Authors:  Siddique A Abbasi; Ravi V Shah; Steven E McNulty; Adrian F Hernandez; Marc J Semigran; Gregory D Lewis; Michael Jerosch-Herold; Raymond J Kim; Margaret M Redfield; Raymond Y Kwong
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

4.  Excessive interatrial adiposity is associated with left atrial remodeling, augmented contractile performance in asymptomatic population.

Authors:  Yau-Huei Lai; Chun-Ho Yun; Cheng-Huang Su; Fei-Shih Yang; Hung-I Yeh; Charles Jia-Yin Hou; Tung-Hsin Wu; Ricardo C Cury; Hiram G Bezerra; Chung-Lieh Hung
Journal:  Echo Res Pract       Date:  2016-01-05

Review 5.  The Role of the Left Atrium: From Multimodality Imaging to Clinical Practice: A Review.

Authors:  Matteo Beltrami; Lorenzo-Lupo Dei; Massimo Milli
Journal:  Life (Basel)       Date:  2022-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.